2026 Q3 Portfolio Activity
In 2026 Q3, ORBIMED ADVISORS LLC maintained a portfolio of 162 distinct positions. The most significant new addition was ADARX PHARMACEUTICALS INC, now representing 8.78% of the total fund value. They heavily accumulated shares in UNITEDHEALTH GROUP INC, increasing the position by 2090.0%. The fund also reduced its exposure to ASTRAZENECA PLC by 58.6%.
Position History
hover any row below to update
Loading…
Total Positions
162
Quarter
2026 Q3
Top Holding
EWTX (11.5%)
Top 10 Concentration
48.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 162
ORBIMED ADVISORS LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 11.46% | 11.68% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
15,518,492 | $630,050,775 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ADRX
ADARX PHARMACEU...
|
Healthcare | 8.78% | — |
#2
Prev: #—
|
8.5 |
—
|
24,205,789 | — |
NEW
|
24,205,789 | $482,663,433 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 5.65% | 6.37% |
#3
1
Prev: #2
|
4.3 |
—
|
no change | no change |
P
S
|
6,776,632 | $310,640,811 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 5.43% | 5.73% |
#4
1
Prev: #3
|
3.7 |
—
|
no change | no change |
P
S
|
257,900 | $298,410,932 | 2001 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BRVE
BRAVEHEART BIO ...
|
Healthcare | 4.47% | — |
#5
Prev: #—
|
5.8 |
—
|
12,175,159 | — |
NEW
|
12,175,159 | $245,938,212 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SVA
SINOVAC BIOTECH...
|
Unknown | 3.56% | 3.42% |
#6
1
Prev: #5
|
2.4 |
—
|
no change | no change |
P
S
|
2,718,735 | $195,500,000 | 2011 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 3.28% | 3.51% |
#7
3
Prev: #4
|
1.8 |
—
|
-353,883 | -10.3% |
P
S
|
3,074,853 | $180,247,883 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MRK
MERCK & CO INC
|
Healthcare | 2.50% | 1.58% |
#8
5
Prev: #13
|
3.5 |
—
|
282,700 | 42.6% |
P
S
|
946,100 | $137,477,791 | 2003 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GH
GUARDANT HEALTH...
|
Healthcare | 1.89% | 1.62% |
#9
2
Prev: #11
|
1.3 |
—
|
400 | 0.1% |
P
S
|
584,100 | $104,180,076 | 2018 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AVBP
ARRIVENT BIOPHA...
|
Healthcare | 1.67% | 1.95% |
#10
Prev: #10
|
1.7 |
—
|
no change | no change |
P
S
|
3,027,328 | $91,667,492 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 1.50% | 1.98% |
#11
2
Prev: #9
|
1.6 |
—
|
no change | no change |
P
S
|
7,165,006 | $82,540,869 | 2016 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NTRA
NATERA INC
|
Healthcare | 1.50% | 1.32% |
#12
8
Prev: #20
|
0.6 |
—
|
-62,300 | -23.8% |
P
S
|
199,700 | $82,538,007 | 2015 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 1.50% | 0.99% |
#13
19
Prev: #32
|
3.6 |
—
|
1,080,100 | 52.9% |
P
S
|
3,122,100 | $82,517,103 | 2020 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 1.48% | 0.84% |
#14
24
Prev: #38
|
3.1 |
—
|
29,700 | 32.7% |
P
S
|
120,400 | $81,276,020 | 2006 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 1.46% | 1.24% |
#15
7
Prev: #22
|
3.1 |
—
|
57,900 | 35.9% |
P
S
|
219,000 | $80,390,520 | 2009 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 1.43% | 1.21% |
#16
8
Prev: #24
|
3.1 |
—
|
100,744 | 41.2% |
P
S
|
345,200 | $78,646,916 | 2015 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ETRA
ELECTRA THERAPE...
|
Healthcare | 1.41% | — |
#17
Prev: #—
|
4.1 |
—
|
6,885,170 | — |
NEW
|
6,885,170 | $77,458,163 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ARGX
ARGENX SE
|
Healthcare | 1.31% | 1.60% |
#18
6
Prev: #12
|
1.0 |
—
|
-17,700 | -19.1% |
P
S
|
75,180 | $72,090,854 | 2017 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 1.31% | 1.40% |
#19
3
Prev: #16
|
1.5 |
—
|
no change | no change |
P
S
|
834,900 | $72,068,568 | 2011 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 1.29% | 0.27% |
#20
58
Prev: #78
|
3.5 |
—
|
947,425 | 374.5% |
P
S
|
1,200,425 | $70,681,024 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 1.26% | — |
#21
Prev: #—
|
4.0 |
—
|
2,777,621 | — |
NEW
|
2,777,621 | $69,301,644 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ABBV
ABBVIE INC
|
Healthcare | 1.24% | — |
#22
Prev: #—
|
4.0 |
—
|
259,600 | — |
NEW
|
259,600 | $67,908,764 | 2013 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CAI
CARIS LIFE SCIE...
|
Healthcare | 1.22% | 0.93% |
#23
13
Prev: #36
|
0.5 |
—
|
-613,900 | -21.9% |
P
S
|
2,192,911 | $67,168,864 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ODTX
ODYSSEY THERAPE...
|
Healthcare | 1.21% | 1.04% |
#24
6
Prev: #30
|
1.5 |
—
|
no change | no change |
P
S
|
3,001,198 | $66,686,620 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 1.17% | 1.21% |
#25
1
Prev: #26
|
2.5 |
—
|
322,400 | 19.2% |
P
S
|
2,003,700 | $64,158,474 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AZNCF
ASTRAZENECA PLC
|
Unknown | 1.12% | 3.17% |
#26
20
Prev: #6
|
0.4 |
—
|
-536,400 | -58.6% |
P
S
|
379,300 | $61,782,783 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CDNA
CAREDX INC
|
Healthcare | 1.11% | — |
#27
Prev: #—
|
3.9 |
—
|
934,800 | — |
NEW
|
934,800 | $60,762,000 | 2019 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 1.06% | 1.43% |
#28
13
Prev: #15
|
0.9 |
—
|
-29,700 | -12.9% |
P
S
|
200,400 | $58,362,492 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ABT
ABBOTT LABORATO...
|
Healthcare | 1.04% | — |
#29
Prev: #—
|
3.9 |
—
|
579,000 | — |
NEW
|
579,000 | $57,222,570 | 2007 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PRLD
PRELUDE THERAPE...
|
Healthcare | 0.98% | 1.36% |
#30
13
Prev: #17
|
1.4 |
—
|
no change | no change |
P
S
|
13,724,571 | $53,663,073 | 2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BLSM
BLOSSOMHILL THE...
|
Healthcare | 0.92% | — |
#31
Prev: #—
|
3.9 |
—
|
2,714,279 | — |
NEW
|
2,714,279 | $50,594,161 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
HUM
HUMANA INC
|
Healthcare | 0.89% | 1.21% |
#32
7
Prev: #25
|
0.4 |
—
|
-36,300 | -22.1% |
P
S
|
127,800 | $48,764,646 | 2010 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
STTK
SHATTUCK LABS I...
|
Healthcare | 0.78% | 0.81% |
#33
8
Prev: #41
|
1.3 |
—
|
no change | no change |
P
S
|
6,306,127 | $43,007,786 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 0.76% | 2.20% |
#34
27
Prev: #7
|
0.3 |
—
|
-878,400 | -39.8% |
P
S
|
1,331,000 | $41,620,370 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 0.73% | 0.46% |
#35
23
Prev: #58
|
2.8 |
—
|
312,300 | 46.2% |
P
S
|
988,487 | $40,162,227 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 0.72% | 1.16% |
#36
8
Prev: #28
|
0.3 |
—
|
-61,100 | -38.7% |
P
S
|
96,800 | $39,361,784 | 2010 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 0.71% | 0.66% |
#37
7
Prev: #44
|
2.8 |
—
|
85,100 | 26.4% |
P
S
|
408,000 | $38,847,720 | 2017 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 0.66% | 1.05% |
#38
9
Prev: #29
|
0.3 |
—
|
-655,728 | -31.1% |
P
S
|
1,454,572 | $36,553,394 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SPRY
ARS PHARMACEUTI...
|
Healthcare | 0.65% | 1.23% |
#39
16
Prev: #23
|
1.3 |
—
|
no change | no change |
P
S
|
8,288,510 | $35,723,478 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
QTTB
Q32 BIO INC
|
Healthcare | 0.62% | 0.97% |
#40
6
Prev: #34
|
1.2 |
—
|
no change | no change |
P
S
|
4,127,987 | $34,138,452 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 0.59% | 0.57% |
#41
8
Prev: #49
|
2.2 |
—
|
14,500 | 17.4% |
P
S
|
97,700 | $32,491,112 | 2019 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 0.58% | 0.83% |
#42
3
Prev: #39
|
0.2 |
—
|
-62,500 | -21.4% |
P
S
|
229,860 | $31,704,590 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 0.57% | 0.53% |
#43
8
Prev: #51
|
2.7 |
—
|
53,300 | 45.3% |
P
S
|
170,878 | $31,508,194 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 0.55% | — |
#44
Prev: #—
|
3.7 |
—
|
131,100 | — |
NEW
|
131,100 | $30,352,272 | 2013 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
UPB
UPSTREAM BIO IN...
|
Healthcare | 0.55% | 0.73% |
#45
3
Prev: #42
|
1.2 |
—
|
no change | no change |
P
S
|
5,693,589 | $30,005,214 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
WST
WEST PHARMACEUT...
|
Healthcare | 0.54% | 0.47% |
#46
10
Prev: #56
|
2.2 |
—
|
9,580 | 13.6% |
P
S
|
80,180 | $29,727,537 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LTGO
LATIGO BIOTHERA...
|
Healthcare | 0.51% | — |
#47
Prev: #—
|
3.7 |
—
|
1,675,316 | — |
NEW
|
1,675,316 | $27,977,777 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CELC
CELCUITY INC
|
Healthcare | 0.45% | — |
#48
Prev: #—
|
3.7 |
—
|
314,500 | — |
NEW
|
314,500 | $25,009,040 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SCTX
SCRIBE THERAPEU...
|
Healthcare | 0.45% | — |
#49
Prev: #—
|
3.7 |
—
|
1,348,825 | — |
NEW
|
1,348,825 | $24,825,124 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DXCM
DEXCOM INC
|
Healthcare | 0.44% | — |
#50
Prev: #—
|
3.7 |
—
|
278,000 | — |
NEW
|
278,000 | $23,988,620 | 2018 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-50 of 162 holdings